Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

NCT00358644 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Decitabine

Sponsor

Eisai Inc.